Cancer Is Not an Infection, But Infections Can Cause It

Cancer is not an infection. It is a disease of altered host cells that divide without normal restraint and can invade tissue. Infections can cause cancer indirectly, by damaging DNA, driving chronic inflammation, or suppressing immune surveillance. Roughly 13% of cancers worldwide are attributable to infectious agents, according to WHO estimates, so the distinction matters clinically: you cannot catch cancer, but you can catch some of its causes.

The confusion is understandable. Both categories involve a foreign threat, both can spread within the body, and both carry stigma. But the biology diverges sharply. Cancer cells are your cells with broken controls. Pathogens are separate organisms with their own genomes and agendas. Treating one as the other leads to real errors in screening, vaccination, and antibiotic use.

Mechanisms: How a Pathogen Pushes a Cell Toward Cancer

A pathogen does not need to become a cancer cell to cause cancer. It needs only to create conditions where host DNA mutates or proliferates.

Several distinct mechanisms operate. Some infectious agents insert their own genes into host DNA. High-risk human papillomavirus (HPV) produces E6 and E7 proteins that disable two key tumor suppressors, p53 and retinoblastoma protein (Rb). With those brakes gone, infected cells accumulate mutations faster. Hepatitis B virus (HBV) can integrate its genome into hepatocyte DNA, causing insertional disruption of host genes. Epstein-Barr virus (EBV) establishes latent infection in B cells and expresses proteins that mimic growth signals.

Other agents act through chronic inflammation. Helicobacter pylori infection of the stomach lining recruits immune cells that release reactive oxygen and nitrogen species. Those molecules damage DNA directly. Sustained inflammation also drives cell turnover, and each division is a chance for a copying error. This is why H. pylori is classified as a group 1 carcinogen by the International Agency for Research on Cancer (IARC), alongside tobacco and asbestos.

A third route is immune evasion. Some pathogens suppress local immune responses, allowing infected or mutated cells to persist when they would otherwise be cleared. This is a cofactor rather than a solo cause.

The common thread: infection creates a permissive environment, but the final malignant transformation is a host-cell event. That is the biologically precise reason cancer is not contagious.

Quantified Context: How Large Is the Infectious Fraction?

The global estimate commonly cited is about 13% of cancers linked to infections (WHO). The exact figure varies by region because pathogen prevalence varies. In sub-Saharan Africa and parts of East Asia, the infectious-attributable fraction runs higher. In high-income countries with vaccination programs, it runs lower.

Specific agents carry specific attributable burdens. HPV is associated with nearly all cervical cancers and a rising share of oropharyngeal cancers in the United States. Chronic HBV and hepatitis C virus (HCV) together account for a majority of hepatocellular carcinoma. H. pylori is linked to most gastric adenocarcinomas and to gastric MALT lymphoma. EBV is associated with nasopharyngeal carcinoma, some Burkitt lymphomas, and lymphomas in immunocompromised people.

The numbers are most useful as priorities, not probabilities. A 13% global figure does not mean any individual has a 13% risk. It means that if you removed those infections from the population, roughly one in eight cancers would not occur.

The table's last row is a professional caveat worth stating. HIV is not a direct carcinogen in the way HPV is. It raises cancer risk mainly by depleting CD4 T cells, which weakens immune control of other viruses such as Kaposi sarcoma herpesvirus. Remove the immune suppression and the associated cancer risk falls.

Edge Cases: Where the Line Gets Blurry

Some situations look like exceptions but are not.

A cancer can spread from person to person in extremely rare circumstances. There are documented cases of cancer transmission through organ transplantation, where donor cancer cells seed in an immunosuppressed recipient. There is also the unusual case of clonal transmissible cancers in animals, such as the Tasmanian devil facial tumor. Neither changes the public health rule that human cancers are not communicable through ordinary contact.

A second edge case is the carrier state. Some people carry an oncogenic virus for decades without developing cancer. HPV infection is common, but most infections clear within one to two years. Only persistent infection with a high-risk type drives precancerous change. So the presence of an oncogenic agent is not equivalent to disease, and that gap is where screening and follow-up matter.

A third edge case is coinfection synergy. HBV and HCV coinfection, or HIV with certain herpesviruses, can accelerate cancer development faster than either agent alone. The mechanism involves compounded immune pressure and inflammation, and the practical implication is that treating the coinfection can alter the trajectory.

The counterintuitive detail: eliminating the infection does not always eliminate the risk immediately. HCV cure with direct-acting antivirals dramatically lowers liver cancer risk, but it does not drop to zero and can take years to manifest in risk reduction. The same is true for H. pylori eradication and gastric cancer. The tissue has already sustained damage, and scars can become sites of later malignancy. This is why surveillance sometimes continues after the cause is gone.

Misconceptions: What People Get Wrong

The first misconception is that cancer is contagious. It is not. You cannot catch cancer through touch, air, or shared meals. You can catch some of its causes, which is a different statement.

The second is that a positive test for an oncogenic virus means cancer is inevitable. It does not. Most HPV infections resolve. Most EBV infections are asymptomatic and lifelong but harmless in immunocompetent people.

The third is that antibiotics treat cancer. They do not treat the cancer itself, but they do treat H. pylori, and eradicating that infection reduces gastric cancer incidence. That is a prevention effect, not a therapy for established tumors.

The fourth is that HPV vaccination is only for girls. Guidance has broadened; vaccination is recommended for boys and girls, and catch-up vaccination is available for certain adult age groups. The specifics change, so check current CDC guidance rather than relying on memory.

The fifth is that a family history of cancer must mean genetic susceptibility. Sometimes it reflects shared exposure to an infectious agent within a household, such as H. pylori or HBV.

Red flags worth acting on: A persistent, unexplained change in a screening result, such as an abnormal cervical cytology follow-up. New chronic digestive symptoms with known H. pylori exposure or a family history of gastric cancer. Signs of liver disease in someone with HBV, HCV, or heavy alcohol use. Unexplained lymph node swelling that persists beyond several weeks. Any new mass or bleeding in an organ system with a known chronic infection.

Practical Actions: What the Evidence Supports

You do not need to memorize pathogen biology. You need a short list of actions with thresholds.

Get vaccinated. HPV vaccination is recommended in early adolescence and is available as catch-up for those who missed it. HBV vaccination is part of routine childhood schedules in many countries and is recommended for unvaccinated adults at risk. These are the two highest-yield cancer-prevention vaccines in routine use.

Follow screening schedules. Cervical cancer screening with cytology or HPV testing is designed to catch precancerous lesions before they become invasive. Colorectal screening is separate but relevant because some pathogens, including certain bacteria, are being studied as contributors to colorectal carcinogenesis; the screening benefit here is established regardless of cause.

Test and treat for H. pylori when indicated. In areas of high gastric cancer incidence or in people with symptoms or family history, testing is reasonable. Eradication reduces cancer risk, though the effect size and timing depend on how much damage predates treatment.

Treat viral hepatitis. HCV is curable with direct-acting antivirals in most cases. HBV is suppressible with antiviral therapy, which lowers but does not eliminate hepatocellular carcinoma risk. Both reduce downstream cancer incidence.

Know your status. HIV testing and early antiretroviral therapy prevent the immune suppression that permits AIDS-defining cancers. This is prevention by preserving immune surveillance, not by killing tumor cells.

What not to do: do not take antibiotics hoping to prevent cancer in general. Antibiotics do not affect HPV, and unnecessary use drives resistance without cancer benefit. Do not assume a negative screening test is a lifetime pass; intervals matter, and those intervals are set by guideline bodies, not by individual preference.

Limitations: What the Evidence Cannot Tell You

The 13% figure is an estimate with wide uncertainty, and it changes as vaccination and treatment coverage change. It also masks regional variation that is larger than the global average suggests.

Most of the mechanistic evidence is associational. We know H. pylori is linked to gastric cancer and that eradication lowers incidence in some trials, but the precise contribution of inflammation versus bacterial factors in any individual case cannot be disentangled. Causality at the population level does not translate to certainty at the individual level.

Screening and vaccination guidelines are updated periodically. Do not treat any specific age cutoff or interval in this article as current clinical advice; those details shift as evidence accumulates.

The hardest limit is this: even with perfect prevention of every known infectious cause, most cancers would remain, because most arise from noninfectious processes such as accumulated mutations, tobacco, radiation, and metabolic factors. Infection is an important lever, not the whole machine.

What you can conclude is narrow and useful. Cancer is a disease of your own cells. Some infections raise the probability that those cells will go wrong. Reducing those infections, through vaccination, screening, and treatment, reduces that probability. The distinction is not semantic. It determines what you can prevent, what you can catch early, and what you should never expect an antibiotic to fix.